APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell therapy platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell therapy platform Market Outlook and Growth Opportunities 2026

4 June 2026194 pages

Choose your research edition.

Industry ResearchCell therapy platform Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell therapy platform Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Cell therapy platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell therapy platform Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell therapy platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global Cell therapy platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell therapy platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell therapy platform market include Novartis, Gilead Sciences, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Roche, Bluebird Bio, Cellectis, Sangamo Therapeutics and Fate Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell therapy platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell therapy platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell therapy platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell therapy platform market.

Cell therapy platform Segment by Company

Novartis

Gilead Sciences

Regeneron Pharmaceuticals

Takeda Pharmaceuticals

Roche

Bluebird Bio

Cellectis

Sangamo Therapeutics

Fate Therapeutics

Cell therapy platform Segment by Type

Autologous Cell Therapy Platform

Allogeneic Cell Therapy Platform

Others

Cell therapy platform Segment by Application

General Hospital

Specialized Hospital

Others

Cell therapy platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell therapy platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell therapy platform key companies, revenue, market share, and recent developments.

3. To split the Cell therapy platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell therapy platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell therapy platform significant trends, drivers, influence factors in global and regions.

6. To analyze Cell therapy platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell therapy platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell therapy platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell therapy platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell therapy platform industry.

Chapter 3: Detailed analysis of Cell therapy platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell therapy platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell therapy platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell therapy platform Industry Trends Table 2. Cell therapy platform Industry Drivers Table 3. Cell therapy platform Industry Opportunities and Challenges Table 4. Cell therapy platform Industry Restraints Table 5. Global Cell therapy platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell therapy platform Revenue Share by Company (2021-2026) Table 7. Global Cell therapy platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell therapy platform Key Company Manufacturing Base & Headquarters Table 9. Global Cell therapy platform Company, Product Type & Application Table 10. Global Cell therapy platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell therapy platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Autologous Cell Therapy Platform Table 15. Significant Companies of Allogeneic Cell Therapy Platform Table 16. Significant Companies of Others Table 17. Global Cell therapy platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cell therapy platform Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cell therapy platform Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cell therapy platform Sales Value Share by Type (2021-2026) Table 21. Global Cell therapy platform Sales Value Share by Type (2027-2032) Table 22. Significant Companies of General Hospital Table 23. Significant Companies of Specialized Hospital Table 24. Significant Companies of Others Table 25. Global Cell therapy platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell therapy platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cell therapy platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cell therapy platform Sales Value Share by Application (2021-2026) Table 29. Global Cell therapy platform Sales Value Share by Application (2027-2032) Table 30. Global Cell therapy platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell therapy platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cell therapy platform Sales Value Share by Region (2021-2026) Table 33. Global Cell therapy platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cell therapy platform Sales Value Share by Region (2027-2032) Table 35. Global Cell therapy platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cell therapy platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cell therapy platform Sales Value Market Share by Country (2021-2026) Table 38. Global Cell therapy platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cell therapy platform Sales Value Market Share by Country (2027-2032) Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Novartis Cell therapy platform Product Portfolio Table 44. Novartis Recent Development Table 45. Gilead Sciences Company Information Table 46. Gilead Sciences Business Overview Table 47. Gilead Sciences Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Gilead Sciences Cell therapy platform Product Portfolio Table 49. Gilead Sciences Recent Development Table 50. Regeneron Pharmaceuticals Company Information Table 51. Regeneron Pharmaceuticals Business Overview Table 52. Regeneron Pharmaceuticals Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Regeneron Pharmaceuticals Cell therapy platform Product Portfolio Table 54. Regeneron Pharmaceuticals Recent Development Table 55. Takeda Pharmaceuticals Company Information Table 56. Takeda Pharmaceuticals Business Overview Table 57. Takeda Pharmaceuticals Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Takeda Pharmaceuticals Cell therapy platform Product Portfolio Table 59. Takeda Pharmaceuticals Recent Development Table 60. Roche Company Information Table 61. Roche Business Overview Table 62. Roche Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Roche Cell therapy platform Product Portfolio Table 64. Roche Recent Development Table 65. Bluebird Bio Company Information Table 66. Bluebird Bio Business Overview Table 67. Bluebird Bio Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bluebird Bio Cell therapy platform Product Portfolio Table 69. Bluebird Bio Recent Development Table 70. Cellectis Company Information Table 71. Cellectis Business Overview Table 72. Cellectis Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cellectis Cell therapy platform Product Portfolio Table 74. Cellectis Recent Development Table 75. Sangamo Therapeutics Company Information Table 76. Sangamo Therapeutics Business Overview Table 77. Sangamo Therapeutics Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sangamo Therapeutics Cell therapy platform Product Portfolio Table 79. Sangamo Therapeutics Recent Development Table 80. Fate Therapeutics Company Information Table 81. Fate Therapeutics Business Overview Table 82. Fate Therapeutics Cell therapy platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Fate Therapeutics Cell therapy platform Product Portfolio Table 84. Fate Therapeutics Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Cell therapy platform Product Image Figure 2. Global Cell therapy platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell therapy platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell therapy platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Autologous Cell Therapy Platform Image Figure 8. Allogeneic Cell Therapy Platform Image Figure 9. Others Image Figure 10. Global Cell therapy platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cell therapy platform Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cell therapy platform Sales Value Share by Type (2021-2032) Figure 13. General Hospital Image Figure 14. Specialized Hospital Image Figure 15. Others Image Figure 16. Global Cell therapy platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cell therapy platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cell therapy platform Sales Value Share by Application (2021-2032) Figure 19. Global Cell therapy platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cell therapy platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cell therapy platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cell therapy platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cell therapy platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cell therapy platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cell therapy platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cell therapy platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cell therapy platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cell therapy platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cell therapy platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cell therapy platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cell therapy platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cell therapy platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cell therapy platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy Platform
  • Allogeneic Cell Therapy Platform
  • Others
Applications
  • General Hospital
  • Specialized Hospital
  • Others
Companies covered
  • Novartis
  • Gilead Sciences
  • Regeneron Pharmaceuticals
  • Takeda Pharmaceuticals
  • Roche
  • Bluebird Bio
  • Cellectis
  • Sangamo Therapeutics
  • Fate Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell therapy platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell therapy platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell therapy platform Market Dynamics
  1. 2.1 Cell therapy platform Industry Trends
  2. 2.2 Cell therapy platform Industry Drivers
  3. 2.3 Cell therapy platform Industry Opportunities and Challenges
  4. 2.4 Cell therapy platform Industry Restraints
3 Cell therapy platform Market by Company
  1. 3.1 Global Cell therapy platform Company Revenue Ranking in 2025
  2. 3.2 Global Cell therapy platform Revenue by Company (2021-2026)
  3. 3.3 Global Cell therapy platform Company Ranking (2024-2026)
  4. 3.4 Global Cell therapy platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell therapy platform Company Product Type and Application
  6. 3.6 Global Cell therapy platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell therapy platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell therapy platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell therapy platform Market by Type
  1. 4.1 Cell therapy platform Type Introduction
  2. 4.1.1 Autologous Cell Therapy Platform
  3. 4.1.2 Allogeneic Cell Therapy Platform
  4. 4.1.3 Others
  5. 4.2 Global Cell therapy platform Sales Value by Type
  6. 4.2.1 Global Cell therapy platform Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cell therapy platform Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cell therapy platform Sales Value Share by Type (2021-2032)
5 Cell therapy platform Market by Application
  1. 5.1 Cell therapy platform Application Introduction
  2. 5.1.1 General Hospital
  3. 5.1.2 Specialized Hospital
  4. 5.1.3 Others
  5. 5.2 Global Cell therapy platform Sales Value by Application
  6. 5.2.1 Global Cell therapy platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cell therapy platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cell therapy platform Sales Value Share by Application (2021-2032)
6 Cell therapy platform Regional Value Analysis
  1. 6.1 Global Cell therapy platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell therapy platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell therapy platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell therapy platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell therapy platform Sales Value (2021-2032)
  7. 6.3.2 North America Cell therapy platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell therapy platform Sales Value (2021-2032)
  10. 6.4.2 Europe Cell therapy platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell therapy platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell therapy platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell therapy platform Sales Value (2021-2032)
  16. 6.6.2 South America Cell therapy platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell therapy platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell therapy platform Sales Value Share by Country, 2025 VS 2032
7 Cell therapy platform Country-level Value Analysis
  1. 7.1 Global Cell therapy platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell therapy platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell therapy platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell therapy platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell therapy platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell therapy platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell therapy platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell therapy platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell therapy platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell therapy platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell therapy platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell therapy platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell therapy platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell therapy platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell therapy platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell therapy platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell therapy platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell therapy platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell therapy platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell therapy platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell therapy platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell therapy platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell therapy platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell therapy platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell therapy platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell therapy platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell therapy platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell therapy platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell therapy platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell therapy platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell therapy platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell therapy platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell therapy platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell therapy platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell therapy platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Cell therapy platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Cell therapy platform Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Gilead Sciences
  8. 8.2.1 Gilead Sciences Company Information
  9. 8.2.2 Gilead Sciences Business Overview
  10. 8.2.3 Gilead Sciences Cell therapy platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Gilead Sciences Cell therapy platform Product Portfolio
  12. 8.2.5 Gilead Sciences Recent Developments
  13. 8.3 Regeneron Pharmaceuticals
  14. 8.3.1 Regeneron Pharmaceuticals Company Information
  15. 8.3.2 Regeneron Pharmaceuticals Business Overview
  16. 8.3.3 Regeneron Pharmaceuticals Cell therapy platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Regeneron Pharmaceuticals Cell therapy platform Product Portfolio
  18. 8.3.5 Regeneron Pharmaceuticals Recent Developments
  19. 8.4 Takeda Pharmaceuticals
  20. 8.4.1 Takeda Pharmaceuticals Company Information
  21. 8.4.2 Takeda Pharmaceuticals Business Overview
  22. 8.4.3 Takeda Pharmaceuticals Cell therapy platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takeda Pharmaceuticals Cell therapy platform Product Portfolio
  24. 8.4.5 Takeda Pharmaceuticals Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Cell therapy platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Cell therapy platform Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Bluebird Bio
  32. 8.6.1 Bluebird Bio Company Information
  33. 8.6.2 Bluebird Bio Business Overview
  34. 8.6.3 Bluebird Bio Cell therapy platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bluebird Bio Cell therapy platform Product Portfolio
  36. 8.6.5 Bluebird Bio Recent Developments
  37. 8.7 Cellectis
  38. 8.7.1 Cellectis Company Information
  39. 8.7.2 Cellectis Business Overview
  40. 8.7.3 Cellectis Cell therapy platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cellectis Cell therapy platform Product Portfolio
  42. 8.7.5 Cellectis Recent Developments
  43. 8.8 Sangamo Therapeutics
  44. 8.8.1 Sangamo Therapeutics Company Information
  45. 8.8.2 Sangamo Therapeutics Business Overview
  46. 8.8.3 Sangamo Therapeutics Cell therapy platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sangamo Therapeutics Cell therapy platform Product Portfolio
  48. 8.8.5 Sangamo Therapeutics Recent Developments
  49. 8.9 Fate Therapeutics
  50. 8.9.1 Fate Therapeutics Company Information
  51. 8.9.2 Fate Therapeutics Business Overview
  52. 8.9.3 Fate Therapeutics Cell therapy platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fate Therapeutics Cell therapy platform Product Portfolio
  54. 8.9.5 Fate Therapeutics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst